{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:09:21Z","timestamp":1760746161387,"version":"build-2065373602"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Hereditary spherocytosis (HS) is a genetic hemolytic disorder primarily characterized by hemolytic anemia, jaundice, splenomegaly, and frequent complications, including cholelithiasis, accompanied by the presence of spherocytes in the peripheral blood. This disorder predominantly follows an autosomal dominant inheritance pattern; however, certain cases exhibit an autosomal recessive mode of inheritance. HS is the most prevalent disorder associated with defects in the red blood cell membrane. Primary myelofibrosis (PMF), a chronic myeloproliferative neoplasm (MPN) characterized by splenomegaly resulting from extramedullary hematopoiesis, is associated with the <jats:italic>JAK2<\/jats:italic> V617F mutation. Currently, there are no documented instances of co-occurrence of HS and PMF in the literature. We report the case of a 37-year-old male who experienced recurrent abdominal distension and splenomegaly over the past decade, along with elevated platelet counts over the past nine years. The patient tested positive for the <jats:italic>JAK2V617F<\/jats:italic> mutation, and bone marrow smears revealed the presence of teardrop-shaped erythrocytes. Peripheral blood smears indicated the presence of approximately 20% of spherocytes. The morphology of the bone marrow biopsy specimen was consistent with an MPN, classified as MF-2 grade. The highly specific eosin-5\u2019-maleimide binding assay demonstrated a reduced mean fluorescence intensity of 25.73%. The patient was managed with aspirin and ruxolitinib and continued to be monitored through follow-up evaluations.<\/jats:p>","DOI":"10.3389\/fonc.2025.1665179","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T04:14:22Z","timestamp":1760674462000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Hereditary spherocytosis concomitant with JAK2V617F-positive primary myelofibrosis: a case report"],"prefix":"10.3389","volume":"15","author":[{"given":"Chi-E","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guosong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuqun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yadan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.704635","article-title":"Splenomegaly in children and adolescents","volume":"9","author":"Suttorp","year":"2021","journal-title":"Front Pediatr"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.11817\/j.issn.1672-7347.2023.220390","article-title":"Clinical and genetic diagnosis for 26 paitents with hereditary spherocytosis","volume":"48","author":"Bai","year":"2023","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2013.04.003","article-title":"Hereditary spherocytosis, elliptocytosis, and other red cell membrane disorders","volume":"27","author":"Da Costa","year":"2013","journal-title":"Blood Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2021.1945237","article-title":"Expression profile analysis reveals hub genes that are associated with immune system dysregulation in primary myelofibrosis","volume":"26","author":"Ma","year":"2021","journal-title":"Hematology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.24018\/ejmed.2023.5.1.1587","article-title":"Review: JAK2V617F allele burden in diagnosis and therapeutic monitoring of myeloproliferative neoplasms","volume":"5","author":"Bhagya","year":"2023","journal-title":"Eur J Med Health Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3906\/sag-2103-247","article-title":"The impact of JAK2V617F mutation on Philadelphia-negative myeloproliferative neoplasms","volume":"52","author":"\u015eahin","year":"2022","journal-title":"Turkish J Med Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13182891","article-title":"The role of the spleen and the place of splenectomy in autoimmune hemolytic anemia-A review of current knowledge","volume":"13","author":"Cvetkovi\u0107","year":"2023","journal-title":"Diagn (Basel Switzerland)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04458-0","article-title":"From multiple sclerosis to organ-specific autoimmune disorders: insights into the molecular and clinical implications of comorbidity","volume":"62","author":"Zabihi","year":"2025","journal-title":"Mol Neurobiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvae163.186","article-title":"8194 Extramedullary hematopoiesis involving bilateral adrenal glands in a patient with sickle cell anemia","volume":"8","author":"Vi","year":"2024","journal-title":"J Endocrine Soc"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3892\/or.2018.6578","article-title":"Analysis of the causes of the misdiagnosis of hereditary spherocytosis","volume":"40","author":"Ma","year":"2018","journal-title":"Oncol Rep"},{"key":"B11","first-page":"1","volume-title":"Classification of blood cells into white blood cells and red blood cells from blood smear images using machine learning techniques","author":"Navya","year":"2021"},{"key":"B12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/bjh.16126","article-title":"Advances in understanding the pathogenesis of red cell membrane disorders","volume":"187","author":"Iolascon","year":"2019","journal-title":"Br J Jaematol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lrr.2022.100332","article-title":"Acquired spherocytosis in the setting of myelodysplasia","volume":"17","author":"Karlsson","year":"2022","journal-title":"Leukemia Res Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.eswa.2024.123660","article-title":"Advancing instance segmentation and WBC classification in peripheral blood smear through domain adaptation: A study on PBC and the novel RV-PBS datasets","volume":"249","author":"Jimut Bahan","year":"2024","journal-title":"Expert Syst Appl"},{"key":"B15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.21037\/atm.2018.07.35","article-title":"Old and new insights into the diagnosis of hereditary spherocytosis","volume":"6","author":"Ciepiela","year":"2018","journal-title":"Ann Trans Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s12185-019-02752-5","article-title":"A megakaryocyte in a peripheral blood smear","volume":"110","author":"Nakai","year":"2019","journal-title":"Int J Hematol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.14082","article-title":"Digital assessment of peripheral blood and bone marrow aspirate smears","author":"Lewis","year":"2023","journal-title":"Int J Lab Hematol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqac016","article-title":"How I diagnose primary myelofibrosis","volume":"157","author":"Sonam","year":"2022","journal-title":"Am J Clin Pathol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2022.0046","article-title":"Myeloproliferative neoplasms, version 3.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Gerds","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e18266","DOI":"10.1097\/MD.0000000000018266","article-title":"Development of myelofibrosis and acute monocytic leukemia in a patient with hereditary spherocytosis: A case report","volume":"98","author":"Qian","year":"2019","journal-title":"Medicine"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1665179\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T04:14:24Z","timestamp":1760674464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1665179\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":21,"alternative-id":["10.3389\/fonc.2025.1665179"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1665179","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"article-number":"1665179"}}